SLN (STOCKS)
Silence Therapeutics Plc American Depository Share
$14.000000
+0.420000 (+3.09%)
Prev close: $13.580000
Company Information
- Exchange
- XNAS
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Iain Gladstone Ross
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $841.06M
- Employees
- 116
- P/E (TTM)
- -11.03
- P/B (TTM)
- 16.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $615.00K |
| Benefits Costs and Expenses | $60.57M |
| Cost Of Revenue | $87.00K |
| Costs And Expenses | $60.57M |
| Gross Profit | $528.00K |
| Operating Expenses | $68.84M |
| Research and Development | $47.56M |
| Other Operating Expenses | $21.27M |
| Operating Income/Loss | -$68.31M |
| Income/Loss From Continuing Operations After Tax | -$59.95M |
| Income/Loss From Continuing Operations Before Tax | -$59.95M |
| Income Tax Expense/Benefit | $2.00K |
| Income Tax Expense/Benefit, Deferred | $2.00K |
| Net Income/Loss | -$59.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$59.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$59.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 283,410,446 |
| Diluted Average Shares | 283,410,446 |
| Assets | $106.41M |
| Current Assets | $94.28M |
| Cash | $72.10M |
| Other Current Assets | $22.18M |
| Noncurrent Assets | $12.13M |
| Fixed Assets | $1.33M |
| Other Non-current Assets | $10.81M |
| Liabilities | $67.94M |
| Current Liabilities | $12.71M |
| Noncurrent Liabilities | $55.23M |
| Equity | $38.47M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $38.47M |
| Liabilities And Equity | $106.41M |
| Net Cash Flow From Operating Activities | -$42.26M |
| Net Cash Flow From Operating Activities, Continuing | -$42.26M |
| Net Cash Flow From Investing Activities | $72.89M |
| Net Cash Flow From Investing Activities, Continuing | $72.89M |
| Net Cash Flow From Financing Activities | $2.00K |
| Net Cash Flow From Financing Activities, Continuing | $2.00K |
| Exchange Gains/Losses | -$315.00K |
| Net Cash Flow | $30.32M |
| Net Cash Flow, Continuing | $30.63M |
| Comprehensive Income/Loss | -$61.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$61.89M |
| Other Comprehensive Income/Loss | -$1.94M |